Asgi

[Asgi @Asgi62553531]

@raja_vm @Akhilkvpnr @amberjain20 @SirigiriChandu @Investingdiary #lauruslabs

https://t.co/RSRRIS9WHf

Please watch from 12.14 onwards Dr Chava as humble as ever thoroughly deserving this award🙏

[Asgi @Asgi62553531]

@raja_vm
Raja Bhai think we 2, @Amberjain20,@Akhilkvpnr ,@SirigiriChandu ,@Investingdiary
& Few others
Need to rejoice today atleast,have took the pain for last so many months,were always with #lauruslabs in thick n thin,don't know about tomorrow, but things do look bright 😊👍

[Asgi @Asgi62553531]

@Akhilkvpnr @raja_vm @amberjain20 @SirigiriChandu @Investingdiary https://t.co/6aetJyZWX5

[Rahul Purwar @purwarrahul2]

Pls join us for the inauguration of ImmunoACT new facility- planned on June 11th by Honourable @bb_thorat. 🙏 to @CEOLaurusLabs @carlhjune @IAmDrDex @DrGauravNarula @TataMemorial @hkJain_kmc @sarya3 @AlkaDwivedi06 @atharvak03 @HighfillSteven @NiraliShahMD for the support.

[NDTV Profit Alpha @NDTVProfitAlpha]

#Q4WithBQ | @LaurusLabs reports 22% decline in net profit even as revenue remains flat in Q4.

CEO Satyanarayana Chava on strategies to accelerate growth. @niraj_shah #BQLive https://t.co/zpJfASusZb

[Asgi @Asgi62553531]

@Akhilkvpnr @raja_vm @SirigiriChandu Don't think they should buyback as they already have good amount of loan on balance sheet, better to invest money in capex and good acquisition as they have been doing, for future growth, then in buybacks and hefty dividends IMHO

[Asgi @Asgi62553531]

@SirigiriChandu @crypotic007 @raja_vm #lauruslabs

2 divides here,All institutions,Fiis,Mutual funds,believe Laurus has a bright future,hense getting every award & increase in stake by Mutual funds and despite heavy fii selling last few months stable stake here,other side is public who are constantly reducing stake.

[Asgi @Asgi62553531]

@Amberjain2015 @raja_vm @amberjain20 @Akhilkvpnr @SirigiriChandu @Investingdiary #Lauruslabs

Looking at UAE and Australian markets for APIs and fdfs as government signing agreements....!

https://t.co/78snvsWJtN

[Asgi @Asgi62553531]

@raja_vm Sabkuch mil jayega to tamanna kiski karoge “Ghalib” 😉
Adhoori khwahishein hi to jeene ka maza deti hain…...😀

[Asgi @Asgi62553531]

@raja_vm #Lauruslabs
When your leader wins so many awards it's so inspiring for all in the company at different levels to give their best, and try to live upto the pace set by the leader 👏

[Asgi @Asgi62553531]

@raja_vm #lauruslabs
Excited that our company has won so many awards in 2021, in almost ever field, by real reputed organizations not a small feat at all, their due diligence is at par. not worried about Q4, but optimistic, real fun will start from Q1 2023 abhi to party shuru hui hai 😉

[Asgi @Asgi62553531]

@SirigiriChandu @raja_vm @itsTarH

[Asgi @Asgi62553531]

@SirigiriChandu @raja_vm @itsTarH #lauruslabs

EOY 2021 'Life Sciences & Healthcare'
category winner Dr. Satyanarayana Chava

https://t.co/pDcCryRgz0

[All India Management Association @aimaindia]

Many congratulations to #SatyanarayanaChava, Founder and CEO, #LaurusLabs for winning the AIMA Emerging Business Leader of Year Award. Mr Chava has carved the 'research' path for a better tomorrow.
#ManagingIndiaAwards #MIA2022

[Asgi @Asgi62553531]

@Amberjain2015 @raja_vm @amberjain20 @Akhilkvpnr @SirigiriChandu @Investingdiary https://t.co/MiWimXNb6o

#Lauruslabs is one above the 19 companies to receive licence to manufacture Plaxovid & supply worldwide as per this article specially Lmic countries where strength of Laurus lies there is huge demand for Plaxovid thus market size is also huge

[Asgi @Asgi62553531]

@Rajesh991Rajesh @Iamsamirarora Just to reach in that stipulated time these bikers drive very agressively jeopardizing theirs and other people's lives around them, most cities here don't have these roads and discipline which can support this types of rash speeds,avoiding problems is better than solving them😊

[Asgi @Asgi62553531]

@raja_vm @Investingdiary @vishwanathank2 @amberjain20 @Akhilkvpnr @SirigiriChandu #lauruslabs

Know your company😊

https://t.co/tdSx3XWek1

[Asgi @Asgi62553531]

@raja_vm @Investingdiary @vishwanathank2 @amberjain20 @Akhilkvpnr @SirigiriChandu #Lauruslabs

A sneak into the future😉😊

https://t.co/fPU0JVNGrB

[Asgi @Asgi62553531]

@unseenvalue @balajiananth Respectedly Agree with your choice Sir,hopefully #Lauruslabs will keep adding smiles to our faces as months roll on 😊
Rightly diversified in sunrise sectors on a massive scale having visionary bold leaders with right integrity thanks 4 your regular guidance regarding the same 🙏

[Asgi @Asgi62553531]

@paani957 Bro vry tempting to believe this 3 pointers makes U think 1) very unusual disclosure which Laurus never gives 2) Laurus does have loads of experience in Arv n can scale pretty fast so a good partner for this 3) price rising in such market,having said this let's hope for the best.

[Asgi @Asgi62553531]

@Akhilkvpnr @raja_vm #lauruslabs think has chosen a much bolder road,wants 2 B the best in APIs, fdfs, Cdmo,n ⭐Bio, more than 1 from these will surely overshoot as all R sunrise sectors & they do have the right talent 2 achieve,feel markets R now sensing this n will surely value & applaud it's path

[Asgi @Asgi62553531]

@raja_vm @vishwanathank2 @amberjain20 @Akhilkvpnr @SirigiriChandu @Investingdiary #lauruslabs
Can be hopeful from this commentry after Q3FY22 results from Aurobindo Pharma today that Arv sales can pick up from Q4 even they have suffered this says Dr Chava was right …source CNBC TV 18.